Co-testing for detection of high-grade cervical intraepithelial neoplasia and cancer compared with cytology alone: A meta-analysis of randomized controlled trials

Journal of Public Health (United Kingdom)

Volumn 36, Issue 1, 2014, Pages 46-55

  Bouchard Fortier, Geneviève ^a,b   Hajifathalian, Kaveh ^a   McKnight, Marla D ^a   Zacharias, David G ^a,c   Gonzalez Gonzalez, Luis Alonso ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

cancer; gynaecological disorders; screening

Indexed keywords

EID: 84897704753     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdt057     Document Type: Article

References (30)

1. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189(1):12-9.
2. Health and Social Care Information Centre, S.a.I.t. Cervical screening programme, England 2011-2012, 2012. http://www.ic.nhs.uk/article/2021/Website- Search?Q=cervical+cancer&go=Go&area=both (4 January 2013, date last accessed).
3. Holschneider C. Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis, 2012.
4. Arbyn M, Anttila A, Jordan J et al. European guidelines for quality assurance in cervical cancer screening, 2nd edn-summary document. Ann Oncol 2010;21(3):448-58.
5. Cuzick J, Clavel C, Petry KU et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119(5):1095-101.
6. Cuzick J, Arbyn M, Sankaranarayanan R et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008;26(Suppl. 10):K29-41.
7. Mayrand MH, Duarte-Franco E, Rodrigues I et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357(16):1579-88.
8. Rijkaart DC, Berkhof J, Rozendaal L et al. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial. Lancet Oncol 2012;13(1):78-88.
9. Ronco G, Giorgi-Rossi P, Carozzi F et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial. Lancet Oncol 2010;11(3):249-57.
10. Bulkmans NW, Berkhof J, Rozendaal L et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007;370(9601):1764-72.
11. Naucler P, Ryd W, Tornberg S et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007;357(16):1589-97.
12. Kitchener HC, Almonte M, Thomson C et al. HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial. Lancet Oncol 2009;10(7):672-82.
13. Moyer VA. Screening for cervical cancer: U.S. preventive services task force recommendation statement. Ann Intern Med 2012;156(12): 880-91.
14. ACOG. New Cervical Cancer Screening Recommendations from the U.S. Preventive Services Task Force and the American Cancer Society/American Society for Colposcopy and Cervical Pathology/American Society for Clinical Pathology. http://www.acog.org/About-ACOG/Announcements/New-Cervical-Cancer-Screening- Recommendations%5D (16 October 2012, date last accessed).
15. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
16. Stroup DF, Berlin JA, Morton SC et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283(15):2008-12.
17. Higgins J, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions. Part 2, Chapter 6.4.11. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
18. Rebolj M, Njor SH, Lynge E. Restriction of human papillomavirus DNA testing in primary cervical screening to women above age 30: systematic review. Eur J Cancer Prev 2012;21(1):73-81.
19. Whitlock EP, Vesco KK, Eder M et al. Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2011;155(10):687-97, W214-5.
20. Solomon D, Davey D, Kurman R et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287(16):2114-9.
21. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7(3):177-88.
22. Castle PE, Schiffman M, Wheeler CM et al. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol 2009;113(1):18-25.
23. Guedes AC, Zeferino LC, Syrjanen KJ et al. Short-term outcome of cervical intraepithelial neoplasia grade 2: considerations for management strategies and reproducibility of diagnosis. Anticancer Res 2010;30(6):2319-23.
24. Darragh TM, Colgan TJ, Cox JT et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: Background and Consensus Recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis 2012;16(3):205-242.
25. Gynecologists, A.C.o.O.a. ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol 2008;112(6):1419-44.
26. McCredie MR, Sharples KJ, Paul C et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9(5):425-34.
27. Murphy J, Kennedy EB, Dunn S et al. HPV testing in primary cervical screening: a systematic review and meta-analysis. J Obstet Gynaecol Can 2012;34(5):443-52.
28. Vesco KK, Whitlock EP, Eder M et al. Screening for cervical cancer: a systematic evidence review for the U.S. preventive services task force. Agency for Healthcare Research and Quality (US): Rockville, MD, 2011.
29. Eltoum IA, Chhieng DC, Roberson J et al. Reflex human papilloma virus infection testing detects the same proportion of cervical intraepithelial neoplasia grade 2-3 in young versus elderly women. Cancer 2005;105(4):194-8.
30. Arbyn M, Kyrgiou M, Simoens C et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008;337:a1284.